Clinical Trial Update: A Study Using Micronised Progesterone (Crinone® 8%) in the Luteal Phase Support of Women Undergoing in Vitro Fertilisation (IVF) and Embryo Transfer (ET) [Phase 3]

View source ↗

Summary

A phase 3 trial evaluating luteal phase support with Crinone 8% micronised progesterone in women undergoing IVF with embryo transfer; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Crinone 8% (progesterone vaginal gel)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility | Phase 3 | Status: COMPLETED